Source: Medical Device Network

Medtronic: Medtronic's defibrillation lead gains FDA approval for use in right ventricle

The US FDA has granted approval for Medtronic's OmniaSecure defibrillation lead intended for insertion in the right ventricular. The post Medtronic's defibrillation lead gains FDA approval for use in right ventricle appeared first on Medical Device Network.

Read full article »
Annual Revenue
$10-50B
Employees
50-100K
Geoffrey S. Martha's photo - Chairman & CEO of Medtronic

Chairman & CEO

Geoffrey S. Martha

CEO Approval Rating

70/100

Read more